Abstract
Arterial involvement, although rare, accounts for significant mortality and morbidity in patients of Behçet’s disease (BD). There is paucity of data on arterial BD. The objective of this 5-year retrospective cohort study was to examine the clinical presentation, pattern of arterial involvement, and treatment outcome in Indian arterial BD patients. Data on demography, clinical presentation, radiology, instituted therapy, vascular interventions and treatment outcomes were recorded and analyzed. Ten (16.9%) out of 59 patients with BD had arterial involvement in 13 vascular territories [mean age 30 (8) years, 9 (90%) males]. Pulmonary artery was most commonly involved (46%), followed by abdominal aorta (15%), femoral artery (15%), descending thoracic aorta (8%), common iliac (8%), and dorsalis pedis artery (8%). Two patients had multi-territory involvement. The median interval between disease onset and development of arterial aneurysms was 3 years (3 months–12 years). Concomitant deep vein thrombosis was seen in 60% cases. Prednisolone and cyclophosphamide were the most common immunosuppressive therapy used; one patient who relapsed on cyclophosphamide responded to infliximab. Five surgical or endovascular interventions were performed. Four patients (40%) died due to aneurysm rupture—all had a delayed diagnosis, and three had pulmonary artery involvement, with death due to massive hemoptysis. Based on the present study, we concluded that arterial involvement in BD is seen predominantly in males and has a high mortality. Early detection and aggressive treatment with immunosuppression and surgical or endovascular interventions are essential for good outcomes.
Availability of data and materials
All data generated or analysed during this study are included in this published article.
Code availability
Not applicable.
References
Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F et al (2013) 2012 Revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65:1–11
Dilsen N (1996) History and development of Behçet’s disease. Rev Rhum Engl Ed 63:512–519
Zou J, Luo JF, Shen Y, Cai JF, Guan JL (2021) Cluster analysis of phenotypes of patients with Behçet’s syndrome: a large cohort study from a referral center in China. Arthritis Res Ther 23(1):45
Soejima Y, Kirino Y, Takeno M, Kurosawa M, Takeuchi M, Yoshimi R et al (2021) Changes in the proportion of clinical clusters contribute to the phenotypic evolution of Behçet’s disease in Japan. Arthritis Res Ther 23(1):49
Seyahi E (2019) Phenotypes in Behçet’s syndrome. Intern Emerg Med 14:677
Emmi G, Bettiol A, Silvestri E, Di Scala G, Becatti M, Fiorillo C et al (2019) Vascular Behçet’s syndrome: an update. Intern Emerg Med 14:645–652
Becatti M, Emmi G, Bettiol A, Silvestri E, Di Scala G, Taddei N et al (2019) Behçet’s syndrome as a tool to dissect the mechanisms of thrombo-inflammation: clinical and pathogenetic aspects. Clin Exp Immunol 195:322–333
Saadoun D, Wechsler B, Desseaux K, Le Thi HD, Amoura Z, Resche-Rigon M et al (2010) Mortality in Behçet’s disease. Arthritis Rheum 62:2806–2812
Park JH, Han MC, Bettmann MA (1984) Arterial manifestations of Behçet disease. Am J Roentgenol 143(4):821–825
Tascilar K, Melikoglu M, Ugurlu S, Sut N, Caglar E, Yazici H (2014) Vascular involvement in Behçet’s syndrome: a retrospective analysis of associations and the time course. Rheumatology (Oxford) 53:2018–2022
Desbois AC, Biard L, Addimanda O, Lambert M, Hachulla E, Launay D et al (2018) Efficacy of anti-TNF alpha in severe and refractory major vessel involvement of Behçet’s disease: a multicenter observational study of 18 patients. Clin Immunol 197:54–59
Zhang X, Dai H, Ma Z, Yang Y, Liu Y (2015) Pulmonary involvement in patients with Behçet’s disease: report of 15 cases. Clin Respir J 9:414–422
Kalko Y, Basaran M, Aydin U, Kafa U, Basaranoglu G, Yasar T (2005) The surgical treatment of arterial aneurysms in Behçet disease: a report of 16 patients. J Vasc Surg 42:673–677
El-Ghobashy N, El-Garf K, Abdo M (2019) Arterial aneurysms in Behçet’s disease patients: frequency, clinical characteristics and long-term outcome. Egypt Rheumatol 41:309–312
Salimi J, Omrani Z, Cheraghali R (2021) Behçet’s disease and multiple arterial aneurysms: 4 case reports. J Surg Case Rep 27(5):rjab200
International Team for the Revision of the International Criteria for Behçet’s Disease (ITR-ICBD) (2014) The International Criteria for Behçet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 28:338–347
Chattopadhyay A, Salvania A, Jain S, Sharma A (2019) A blind man with an acute abdomen. Rheumatology (Oxford) 58:858
Chhabria B, Sharma A, Agarwal R, Muthu V (2019) An unusual cause of massive hemoptysis: the demise of clinical history and a teachable moment from a fatal case. Lung India 36:365–366
Yazici H, Seyahi E, Hatemi G, Yazici Y (2018) Behçet syndrome: a contemporary view. Nat Rev Rheumatol 14:107–119
Melikoglu M, Kural-Seyahi E, Tascilar K, Yazici H (2008) The unique features of vasculitis in Behçet’s syndrome. Clin Rev Allergy Immunol 35:40–46
Hatemi G, Christensen R, Bang D, Bodaghi B, Celik AF, Fortune F et al (2018) 2018 update of the EULAR recommendations for the management of Behçet’s syndrome. Ann Rheum Dis 77:808–818
Alibaz-Oner F, Direskeneli H (2019) Management of vascular Behçet’s disease. Int J Rheum Dis 22(Suppl 1):105–108
Hamuryudan V, Seyahi E, Ugurlu S, Melikoglu M, Hatemi G, Ozguler Y et al (2015) Pulmonary artery involvement in Behçet’s syndrome: effects of anti-Tnf treatment. Semin Arthritis Rheum 45:369–373
Rossi GM, Emmi G, Vaglio A (2018) Hemoptysis in Behçet’s syndrome: from bedside to bench? Intern Emerg Med 13:467–469
Voiriot G, Parrot A, Antoine M, Gibelin A, Haddad S, Carette MF et al (2018) Transcatheter embolo-therapy of pulmonary artery aneurysms as emergency treatment of hemoptysis in Behçet patients: experience of a referral center and a review of the literature. Intern Emerg Med 13:491–500
Funding
No specific funding was received from any bodies in the public, commercial or not-for-profit sectors to carry out the work described in this article.
Author information
Authors and Affiliations
Contributions
AC and AmS conceptualized the study. AC, SiJ, BC and NA collected, analysed and interpreted the data. AC, SiJ and AmS drafted the manuscript. GN, VD, VM, AjS, RV and SaJ provided critical, intellectual inputs on the same. MS interpreted and analysed the radiological data. AjS was involved in surgical management, while RV performed percutaneous interventions. All co-authors approved the final submitted version of the manuscript. All co-authors take full responsibility for all aspects of the work and meet all four criteria for authorship recommended by the ICMJE.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest.
Ethics approval
This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Institutional Ethics Committee of Postgraduate Institute of Medical Education and Research, Chandigarh, India (INT/IEC/2021/SPL-126, dated 22.01.2021).
Consent to participate
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Chattopadhyay, A., Jain, S., Naidu, G.S.R.S.N.K. et al. Clinical presentation and treatment outcomes of arterial involvement in Behçet’s disease: a single-centre experience. Rheumatol Int 42, 115–120 (2022). https://doi.org/10.1007/s00296-021-05022-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-021-05022-y